| Product Code: ETC13167905 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Middle East Pharmacogenetic Testing Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Middle East Pharmacogenetic Testing Market Overview |
3.1 Middle East Regional Macro Economic Indicators |
3.2 Middle East Pharmacogenetic Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Middle East Pharmacogenetic Testing Market - Industry Life Cycle |
3.4 Middle East Pharmacogenetic Testing Market - Porter's Five Forces |
3.5 Middle East Pharmacogenetic Testing Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Middle East Pharmacogenetic Testing Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Middle East Pharmacogenetic Testing Market Revenues & Volume Share, By Gene Type, 2021 & 2031F |
3.8 Middle East Pharmacogenetic Testing Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.9 Middle East Pharmacogenetic Testing Market Revenues & Volume Share, By Sample, 2021 & 2031F |
3.10 Middle East Pharmacogenetic Testing Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.11 Middle East Pharmacogenetic Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.12 Middle East Pharmacogenetic Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Middle East Pharmacogenetic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Middle East Pharmacogenetic Testing Market Trends |
6 Middle East Pharmacogenetic Testing Market, 2021 - 2031 |
6.1 Middle East Pharmacogenetic Testing Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Middle East Pharmacogenetic Testing Market, Revenues & Volume, By Whole Genome Sequencing, 2021 - 2031 |
6.1.3 Middle East Pharmacogenetic Testing Market, Revenues & Volume, By Whole Exome Sequencing, 2021 - 2031 |
6.1.4 Middle East Pharmacogenetic Testing Market, Revenues & Volume, By Array-Based Tests, 2021 - 2031 |
6.1.5 Middle East Pharmacogenetic Testing Market, Revenues & Volume, By Single Gene Tests, 2021 - 2031 |
6.2 Middle East Pharmacogenetic Testing Market, Revenues & Volume, By Gene Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Middle East Pharmacogenetic Testing Market, Revenues & Volume, By CYP2C19, 2021 - 2031 |
6.2.3 Middle East Pharmacogenetic Testing Market, Revenues & Volume, By CYP2D6, 2021 - 2031 |
6.2.4 Middle East Pharmacogenetic Testing Market, Revenues & Volume, By CYP2C9 and VKORC1, 2021 - 2031 |
6.2.5 Middle East Pharmacogenetic Testing Market, Revenues & Volume, By CYP1A2, 2021 - 2031 |
6.2.6 Middle East Pharmacogenetic Testing Market, Revenues & Volume, By HLA-B*1502, 2021 - 2031 |
6.2.7 Middle East Pharmacogenetic Testing Market, Revenues & Volume, By HLA-B*5701, 2021 - 2031 |
6.2.8 Middle East Pharmacogenetic Testing Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3 Middle East Pharmacogenetic Testing Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Middle East Pharmacogenetic Testing Market, Revenues & Volume, By Prescription Drugs, 2021 - 2031 |
6.3.3 Middle East Pharmacogenetic Testing Market, Revenues & Volume, By Nutraceuticals, 2021 - 2031 |
6.3.4 Middle East Pharmacogenetic Testing Market, Revenues & Volume, By Recreational Drugs, 2021 - 2031 |
6.3.5 Middle East Pharmacogenetic Testing Market, Revenues & Volume, By Herbal Supplements, 2021 - 2031 |
6.3.6 Middle East Pharmacogenetic Testing Market, Revenues & Volume, By Vitamins, 2021 - 2031 |
6.3.7 Middle East Pharmacogenetic Testing Market, Revenues & Volume, By Over-the-Counter Medications, 2021 - 2031 |
6.4 Middle East Pharmacogenetic Testing Market, Revenues & Volume, By Sample, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Middle East Pharmacogenetic Testing Market, Revenues & Volume, By Blood, 2021 - 2031 |
6.4.3 Middle East Pharmacogenetic Testing Market, Revenues & Volume, By Saliva, 2021 - 2031 |
6.5 Middle East Pharmacogenetic Testing Market, Revenues & Volume, By Therapeutic Area, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Middle East Pharmacogenetic Testing Market, Revenues & Volume, By Cardiology, 2021 - 2031 |
6.5.3 Middle East Pharmacogenetic Testing Market, Revenues & Volume, By Gastroenterology, 2021 - 2031 |
6.5.4 Middle East Pharmacogenetic Testing Market, Revenues & Volume, By Anesthesiology, 2021 - 2031 |
6.5.5 Middle East Pharmacogenetic Testing Market, Revenues & Volume, By Genomics, 2021 - 2031 |
6.5.6 Middle East Pharmacogenetic Testing Market, Revenues & Volume, By Endocrinology, 2021 - 2031 |
6.5.7 Middle East Pharmacogenetic Testing Market, Revenues & Volume, By Immunology & Hypersensitivity, 2021 - 2031 |
6.5.8 Middle East Pharmacogenetic Testing Market, Revenues & Volume, By Dermatology, 2021 - 2031 |
6.5.9 Middle East Pharmacogenetic Testing Market, Revenues & Volume, By Others, 2021 - 2031 |
6.6 Middle East Pharmacogenetic Testing Market, Revenues & Volume, By Application, 2021 - 2031 |
6.6.1 Overview & Analysis |
6.6.2 Middle East Pharmacogenetic Testing Market, Revenues & Volume, By Clinical Practice, 2021 - 2031 |
6.6.3 Middle East Pharmacogenetic Testing Market, Revenues & Volume, By Drug Development, 2021 - 2031 |
6.6.4 Middle East Pharmacogenetic Testing Market, Revenues & Volume, By Drug Regulation, 2021 - 2031 |
6.7 Middle East Pharmacogenetic Testing Market, Revenues & Volume, By End User, 2021 - 2031 |
6.7.1 Overview & Analysis |
6.7.2 Middle East Pharmacogenetic Testing Market, Revenues & Volume, By Healthcare Providers, 2021 - 2031 |
6.7.3 Middle East Pharmacogenetic Testing Market, Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021 - 2031 |
6.7.4 Middle East Pharmacogenetic Testing Market, Revenues & Volume, By Centres and Academic Institutes, 2021 - 2031 |
6.7.5 Middle East Pharmacogenetic Testing Market, Revenues & Volume, By Others, 2021 - 2031 |
7 Middle East Pharmacogenetic Testing Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Middle East Pharmacogenetic Testing Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.1 Saudi Arabia Pharmacogenetic Testing Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.2 UAE Pharmacogenetic Testing Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.3 Kuwait Pharmacogenetic Testing Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.4 Qatar Pharmacogenetic Testing Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.5 Bahrain Pharmacogenetic Testing Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.6 Oman Pharmacogenetic Testing Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.7 Turkey Pharmacogenetic Testing Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.8 Rest of Middle East Pharmacogenetic Testing Market, Revenues & Volume, By Type, 2021 - 2031 |
7.3 Middle East Pharmacogenetic Testing Market Revenues & Volume Share, By Gene Type, 2021 & 2031F |
7.3.1 Saudi Arabia Pharmacogenetic Testing Market, Revenues & Volume, By Gene Type, 2021 - 2031 |
7.3.2 UAE Pharmacogenetic Testing Market, Revenues & Volume, By Gene Type, 2021 - 2031 |
7.3.3 Kuwait Pharmacogenetic Testing Market, Revenues & Volume, By Gene Type, 2021 - 2031 |
7.3.4 Qatar Pharmacogenetic Testing Market, Revenues & Volume, By Gene Type, 2021 - 2031 |
7.3.5 Bahrain Pharmacogenetic Testing Market, Revenues & Volume, By Gene Type, 2021 - 2031 |
7.3.6 Oman Pharmacogenetic Testing Market, Revenues & Volume, By Gene Type, 2021 - 2031 |
7.3.7 Turkey Pharmacogenetic Testing Market, Revenues & Volume, By Gene Type, 2021 - 2031 |
7.3.8 Rest of Middle East Pharmacogenetic Testing Market, Revenues & Volume, By Gene Type, 2021 - 2031 |
7.4 Middle East Pharmacogenetic Testing Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.4.1 Saudi Arabia Pharmacogenetic Testing Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.4.2 UAE Pharmacogenetic Testing Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.4.3 Kuwait Pharmacogenetic Testing Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.4.4 Qatar Pharmacogenetic Testing Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.4.5 Bahrain Pharmacogenetic Testing Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.4.6 Oman Pharmacogenetic Testing Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.4.7 Turkey Pharmacogenetic Testing Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.4.8 Rest of Middle East Pharmacogenetic Testing Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.5 Middle East Pharmacogenetic Testing Market, Revenues & Volume, By Sample, 2021 - 2031 |
7.5.1 Saudi Arabia Pharmacogenetic Testing Market, Revenues & Volume, By Sample, 2021 - 2031 |
7.5.2 UAE Pharmacogenetic Testing Market, Revenues & Volume, By Sample, 2021 - 2031 |
7.5.3 Kuwait Pharmacogenetic Testing Market, Revenues & Volume, By Sample, 2021 - 2031 |
7.5.4 Qatar Pharmacogenetic Testing Market, Revenues & Volume, By Sample, 2021 - 2031 |
7.5.5 Bahrain Pharmacogenetic Testing Market, Revenues & Volume, By Sample, 2021 - 2031 |
7.5.6 Oman Pharmacogenetic Testing Market, Revenues & Volume, By Sample, 2021 - 2031 |
7.5.7 Turkey Pharmacogenetic Testing Market, Revenues & Volume, By Sample, 2021 - 2031 |
7.5.8 Rest of Middle East Pharmacogenetic Testing Market, Revenues & Volume, By Sample, 2021 - 2031 |
7.6 Middle East Pharmacogenetic Testing Market, Revenues & Volume, By Therapeutic Area, 2021 - 2031 |
7.6.1 Saudi Arabia Pharmacogenetic Testing Market, Revenues & Volume, By Therapeutic Area, 2021 - 2031 |
7.6.2 UAE Pharmacogenetic Testing Market, Revenues & Volume, By Therapeutic Area, 2021 - 2031 |
7.6.3 Kuwait Pharmacogenetic Testing Market, Revenues & Volume, By Therapeutic Area, 2021 - 2031 |
7.6.4 Qatar Pharmacogenetic Testing Market, Revenues & Volume, By Therapeutic Area, 2021 - 2031 |
7.6.5 Bahrain Pharmacogenetic Testing Market, Revenues & Volume, By Therapeutic Area, 2021 - 2031 |
7.6.6 Oman Pharmacogenetic Testing Market, Revenues & Volume, By Therapeutic Area, 2021 - 2031 |
7.6.7 Turkey Pharmacogenetic Testing Market, Revenues & Volume, By Therapeutic Area, 2021 - 2031 |
7.6.8 Rest of Middle East Pharmacogenetic Testing Market, Revenues & Volume, By Therapeutic Area, 2021 - 2031 |
7.7 Middle East Pharmacogenetic Testing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.7.1 Saudi Arabia Pharmacogenetic Testing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.7.2 UAE Pharmacogenetic Testing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.7.3 Kuwait Pharmacogenetic Testing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.7.4 Qatar Pharmacogenetic Testing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.7.5 Bahrain Pharmacogenetic Testing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.7.6 Oman Pharmacogenetic Testing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.7.7 Turkey Pharmacogenetic Testing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.7.8 Rest of Middle East Pharmacogenetic Testing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.8 Middle East Pharmacogenetic Testing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.8.1 Saudi Arabia Pharmacogenetic Testing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.8.2 UAE Pharmacogenetic Testing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.8.3 Kuwait Pharmacogenetic Testing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.8.4 Qatar Pharmacogenetic Testing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.8.5 Bahrain Pharmacogenetic Testing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.8.6 Oman Pharmacogenetic Testing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.8.7 Turkey Pharmacogenetic Testing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.8.8 Rest of Middle East Pharmacogenetic Testing Market, Revenues & Volume, By End User, 2021 - 2031 |
8 Middle East Pharmacogenetic Testing Market Key Performance Indicators |
9 Middle East Pharmacogenetic Testing Market - Export/Import By Countries Assessment |
10 Middle East Pharmacogenetic Testing Market - Opportunity Assessment |
10.1 Middle East Pharmacogenetic Testing Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Middle East Pharmacogenetic Testing Market Opportunity Assessment, By Type, 2021 & 2031F |
10.3 Middle East Pharmacogenetic Testing Market Opportunity Assessment, By Gene Type, 2021 & 2031F |
10.4 Middle East Pharmacogenetic Testing Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
10.5 Middle East Pharmacogenetic Testing Market Opportunity Assessment, By Sample, 2021 & 2031F |
10.6 Middle East Pharmacogenetic Testing Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
10.7 Middle East Pharmacogenetic Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
10.8 Middle East Pharmacogenetic Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
11 Middle East Pharmacogenetic Testing Market - Competitive Landscape |
11.1 Middle East Pharmacogenetic Testing Market Revenue Share, By Companies, 2022 |
11.2 Middle East Pharmacogenetic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here